Pharmsynthez (MOEX:LIFE)
Russia flag Russia · Delayed Price · Currency is RUB
4.505
+0.415 (10.15%)
At close: Jul 8, 2022

Pharmsynthez Balance Sheet

Millions RUB. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1.541.524.989.1715.310.41
Short-Term Investments
-2.54----
Cash & Short-Term Investments
1.544.064.989.1715.310.41
Cash Growth
-72.95%-18.50%-45.74%-40.03%46.89%-84.44%
Accounts Receivable
193.3928.8796.0172.0369.0666.02
Other Receivables
-145.12169.020.88.03164.1
Receivables
193.39174265.0377.5579.21288.79
Inventory
58.9962.6263.5641.9536.1969.56
Prepaid Expenses
---69.3875.5496.32
Other Current Assets
0.921.636.210.040.040.04
Total Current Assets
254.83262.27369.79198.1206.27465.13
Property, Plant & Equipment
408.78430.94468.54344.58326.7352.12
Long-Term Investments
777.36781.5793.1433.5125.14487.73
Other Intangible Assets
211.86211.86216.21331.9337.23349.83
Long-Term Deferred Tax Assets
957.161,0411,086366.61365.25329.17
Other Long-Term Assets
---63.2363.2368.2
Total Assets
2,6102,7272,9341,3381,4252,052

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Accounts Payable
488.37530.94442.52178.66141.29177.76
Accrued Expenses
-16.8115.63105.61104.1883.88
Short-Term Debt
359.52361.85335591.72579.81573.52
Current Portion of Long-Term Debt
---103.2241.5535.85
Current Portion of Leases
-0.939.878.69-0.95
Current Income Taxes Payable
---29.2315.5512.31
Other Current Liabilities
22.793.1543.75157.93110.95140.58
Total Current Liabilities
870.67913.67846.771,175993.331,025
Long-Term Debt
81.32--16.5586.8513.2
Long-Term Leases
-0.9320.1525.22--
Total Liabilities
952914.6866.921,2171,0801,038

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Common Stock
2,2022,2022,2021,5051,5051,505
Additional Paid-In Capital
4,8534,8534,8533,5313,5313,531
Retained Earnings
-5,397-5,242-4,988-4,445-4,238-3,540
Comprehensive Income & Other
000-469.45-452.76-481.47
Total Common Equity
1,6581,8132,067121.1345.281,014
Shareholders' Equity
1,6581,8132,067121.1345.281,014
Total Liabilities & Equity
2,6102,7272,9341,3381,4252,052

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Total Debt
440.84363.71365.02745.4708.21623.52
Net Cash (Debt)
-439.3-359.65-360.04-736.23-692.91-613.1
Net Cash Growth
------
Net Cash Per Share
-0.98-0.82-0.82-2.45-2.30-2.04
Filing Date Shares Outstanding
487.98440.39456.83301.01301.01301.01
Total Common Shares Outstanding
487.98440.39456.83301.01301.01301.01
Working Capital
-615.85-651.4-476.98-976.95-787.05-559.73
Book Value Per Share
3.404.124.520.401.153.37
Tangible Book Value
1,4461,6011,850-210.88.05664.29
Tangible Book Value Per Share
2.963.634.05-0.700.032.21
Land
-181.5150.73161.11159.14155.22
Buildings
-160.7182.39---
Machinery
-323.29320.59515.92523.17541
Construction In Progress
---143.66143.66143.66